{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:26:58Z","timestamp":1769020018437,"version":"3.49.0"},"reference-count":19,"publisher":"Baishideng Publishing Group Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Gastrointest Surg"],"abstract":"<jats:p>BACKGROUND<\/jats:p>\n                  <jats:p>Although most acute pancreatitis (AP) cases are mild, up to 20% progress to severe disease, leading to substantial morbidity and mortality. Early risk stratification remains challenging because conventional scoring systems require multiple parameters and often depend on 24-48 hours of observation.<\/jats:p>\n                  <jats:p>AIM<\/jats:p>\n                  <jats:p>To evaluate whether serum phosphate levels measured upon hospital admission can predict disease severity and short-term clinical outcomes in patients with AP.<\/jats:p>\n                  <jats:p>METHODS<\/jats:p>\n                  <jats:p>We retrospectively analyzed 1000 consecutive patients hospitalized for AP between November 2023 and June 2025. Admission phosphate was categorized as hypophosphatemia (&lt; 2.5 mg\/dL), normophosphatemia (2.5-4.5 mg\/dL), or hyperphosphatemia (&gt; 4.5 mg\/dL). Clinical outcomes included severe AP (SAP), pancreatic necrosis, intensive care unit (ICU) admission, and 30-day all-cause mortality. Multivariable logistic regression was performed to evaluate the independent association between phosphate levels and clinical outcomes, with additional models adjusted for creatinine levels and acute kidney injury (AKI).<\/jats:p>\n                  <jats:p>RESULTS<\/jats:p>\n                  <jats:p>SAP occurred in 60% of patients with hyperphosphatemia and in 20% of those with normophosphatemia (P  &lt; 0.001). Pancreatic necrosis (50% vs  10%) and ICU admission (70% vs  15%) were also significantly more frequent in the hyperphosphatemia group. Thirty-day mortality was 25% in the hyperphosphatemia group and 3% in the normophosphatemia group. Hyperphosphatemia independently predicted 30-day mortality (adjusted OR 5.8; 95%CI: 2.9-11.5; P  &lt; 0.001), and this association remained significant after adjustment for creatinine and AKI (adjusted OR 4.7; 95%CI: 2.1-10.3; P  &lt; 0.001).<\/jats:p>\n                  <jats:p>CONCLUSION<\/jats:p>\n                  <jats:p>Admission hyperphosphatemia independently predicts severe disease, pancreatic necrosis, ICU admission, and early mortality, highlighting a simple and inexpensive biomarker to support rapid risk stratification in AP.<\/jats:p>","DOI":"10.4240\/wjgs.v18.i1.114227","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:11:54Z","timestamp":1768965114000},"source":"Crossref","is-referenced-by-count":0,"title":["Admission hyperphosphatemia as a predictor of severity and mortality in acute pancreatitis: A 1000-patient cohort study"],"prefix":"10.4240","volume":"18","author":[{"given":"Yavuz","family":"\u00d6zden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuh Mehmet","family":"Buyukberber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00856.x"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2024.24392"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.218"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000002248"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12059"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-023-02034-2"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000002265"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.12094"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302779"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000002459"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000002344"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34149"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.17161\/kjm.vol15.18129"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00022.2022"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000002455"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.152702"},{"key":"B17","unstructured":"Rizos E, Alexandrides G, Elisaf MS. Severe hypophosphatemia in a patient with acute pancreatitis. JOP 2000; 204-207"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1526122"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/s41065-025-00466-9"}],"container-title":["World Journal of Gastrointestinal Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1948-9366\/full\/v18\/i1\/114227.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/1948-9366\/full\/v18\/i1\/114227.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:13:52Z","timestamp":1768965232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1948-9366\/full\/v18\/i1\/114227.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":19,"journal-issue":{"issue":"1"},"alternative-id":["114227"],"URL":"https:\/\/doi.org\/10.4240\/wjgs.v18.i1.114227","relation":{},"ISSN":["1948-9366"],"issn-type":[{"value":"1948-9366","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,27]]}}}